Entre las marcas de nuestros más de 25 colaboradores destaca TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina el 31 dic( quedan 9 días )
IGUANA-1
CAS:<p>IGUANA-1 is a highly efficient and selective ALDH1B1 inhibitor that inhibits the growth of colorectal cancer cells and colorectal cancer cell-derived organoids.</p>Fórmula:C27H26ClN3O4Pureza:99.08%Forma y color:SolidPeso molecular:491.97MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Fórmula:C19H17ClFN7O2SForma y color:SolidPeso molecular:461.9TMV-IN-1
CAS:TMV-IN-1: a chalcone inhibits TMV with EC50s of 70.7 and 60.8 μg/mL, applicable in infection and tumor studies.Fórmula:C28H26O4Forma y color:SolidPeso molecular:426.5DHBP dibromide
CAS:<p>DHBP dibromide (1,1'-DI-N-HEPTYL-4,4'-BIPYRIDINIUM DIBRO) is calcium release and a muscle relaxant inhibitor.</p>Fórmula:C24H38Br2N2Pureza:99.73%Forma y color:Yellow To Yellow-Green Powder Or FlakesPeso molecular:514.38CK2-IN-6
CAS:CK2-IN-6: Potent CK2 inhibitor for cancer, inflammation, pain, and immune research.Fórmula:C19H16ClN7O2Forma y color:SolidPeso molecular:409.83BGB-8035
CAS:<p>BGB-8035 is a BTK inhibitor with antitumor activity that inhibits BTK, TEC, and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.</p>Fórmula:C24H31N5O4Pureza:96.74%Forma y color:SolidPeso molecular:453.53SZM-1209
CAS:<p>SZM-1209 is a potent and specific RIPK1 inhibitor with oral activity, displaying a dissociation constant (Kd) of 85 nM.</p>Fórmula:C31H29F5N4O5S2Pureza:98%Forma y color:SolidPeso molecular:696.71GLPG3970
CAS:GLPG3970, a pioneering inhibitor of SIK2/SIK3, is utilized in the investigation of inflammation and autoimmune diseases.Fórmula:C25H27F3N4O4Pureza:99.60% - >99.99%Forma y color:SolidPeso molecular:504.5DKFZ-748
CAS:<p>DKFZ-748 is a selective HDAC10 inhibitor and has a dose-dependent growth inhibitory effect on HeLa cells.</p>Fórmula:C18H23N3O3Pureza:98.10%Forma y color:SolidPeso molecular:329.39RGT-068A
CAS:RGT-068A is a potent, selective and oral bioavailable MALT1 inhibitor .Fórmula:C17H16ClN9O2Forma y color:SolidPeso molecular:413.82DHBP
CAS:<p>DHBP (Benzoresorcinol) is an WalKR TCS activator.</p>Fórmula:C13H10O3Pureza:99.95%Forma y color:Light-Yellow Solid CrystallinePeso molecular:214.22Angiotensin (1-7)
CAS:Angiotensin (1-7) (ASP-ARG-VAL-TYR-ILE-HIS-PRO) is a synthetic heptapeptide, inhibits canine ACE activity with vasodilator and antiproliferative activities.Fórmula:C41H62N12O11Pureza:>99.99%Forma y color:White Lyophilised SolidPeso molecular:899I-BET432
I-BET432, a BET inhibitor, blocks BRD4 BD1/BD2 (pIC50: 7.5/7.2), is oral, and targets cancer/inflammation.Fórmula:C18H21N3O3Forma y color:SolidPeso molecular:327.38BLM-IN-2
BLM-IN-2: BLM inhibitor, IC50=0.8 μM; hinders CRC cell growth, invasion, cycle arrest, and death.Fórmula:C33H38BrFN4OForma y color:SolidPeso molecular:605.58TUL01101
CAS:<p>TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.</p>Fórmula:C22H25F2N5O2Forma y color:SolidPeso molecular:429.46BAY-7081
BAY-7081 is a cyanopyridone-based compound that functions as a potent, selective, and orally active PDE9A inhibitor, demonstrating an inhibition concentration (Fórmula:C19H27ClN4OForma y color:SolidPeso molecular:362.9ASPER-29
CAS:ASPER-29, an Asperphenamate analog, inhibits cathepsins L/S with IC50s of 6.03/5.02 μM, useful in cancer migration/invasion research.Fórmula:C31H29BrN2O5SForma y color:SolidPeso molecular:621.54ARS-2102
CAS:ARS-2102 is a potent covalent KRAS G12C inhibitor for use in cancer research .Fórmula:C28H31ClF2N6O2Forma y color:SolidPeso molecular:557.03ENT-C225
CAS:ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.Fórmula:C26H40N4O5Pureza:99.36% - 99.36%Forma y color:SolidPeso molecular:488.62FTX-6746
CAS:FTX-6746 is an orally active and selective PPARG reverse inhibitor with anticancer activity. It can be used in research on urothelial carcinoma.Fórmula:C16H7ClF2N2OPureza:98.68%Forma y color:SolidPeso molecular:316.695'-N-Ethylcarboxamidoadenosine
CAS:<p>NECA, an adenosine receptor agonist, boosts brain extravasation of fluorescein and dextran without affecting the blood-brain barrier.</p>Fórmula:C12H16N6O4Pureza:98.95% - ≥95%Forma y color:PowderPeso molecular:308.29PG-11047
CAS:PG-11047 (CGC-11047) is a polyamine analogue utilized in breast cancer research.Fórmula:C14H32N4Forma y color:SolidPeso molecular:256.43PG-11047 2HCl
PG-11047 2HCl treats genitourinary, immune, genetic, ocular, blood/lymphatic disorders, and aids lymphoma/prostate cancer research.Fórmula:C14H34Cl2N4Pureza:97.47%Forma y color:SolidPeso molecular:329.35Debneyol
CAS:Debneyol exhibits more potent fungicidal activity than validamycin.Fórmula:C15H26O2Forma y color:SolidPeso molecular:238.37Flavipin
CAS:<p>Flavipin: Ahr agonist, alters Ahr genes in T cells/macrophages, disrupts Arid5a, scavenges DPPH (IC50=7.2μM), inhibits α-glucosidase (IC50=33.8μM).</p>Fórmula:C9H8O5Forma y color:SolidPeso molecular:196.16Aviculin
CAS:Aviculin, a lignan glycoside, exhibits anticancer properties by inducing apoptosis in breast cancer cells with an IC50 of 75.47 μM.Fórmula:C26H34O10Forma y color:SolidPeso molecular:506.54JNJ-9350
CAS:<p>JNJ-9350: SMOX inhibitor (IC50 0.01 μM), PAO inhibitor (IC50 0.79 μM), for cancer research.</p>Fórmula:C25H22N6OForma y color:SolidPeso molecular:422.48Immepip
CAS:Immepip, a H3 agonist, has been shown to attenuate cortical histamine release and is utilized in the research of neurological diseases.Fórmula:C9H15N3Forma y color:SolidPeso molecular:165.24SBI-993
CAS:SBI-993 is a potent SBI-477 analog with good pharmacokinetics and enhances insulin signaling by inhibiting MondoA.Fórmula:C23H24N4O4SForma y color:SolidPeso molecular:452.53Diclofensine
CAS:<p>Diclofensine (Ro 8-4650) inhibits the uptake of serotonin, noradrenaline and dopamine.</p>Fórmula:C17H17Cl2NOPureza:97.01% - 98.13%Forma y color:SolidPeso molecular:322.23MK-4541
CAS:<p>MK-4541: oral, selective AR modulator, blocks 5α-reductase, curbs AR+ prostate cancer growth, effective in mouse model.</p>Fórmula:C22H31F3N2O3Forma y color:SolidPeso molecular:428.49PV-1019
CAS:PV-1019 (NSC 744039), a potent Chk2 inhibitor, has an IC50 of 24 nM and blocks Chk2 autophosphorylation and IR-induced apoptosis.Fórmula:C18H17N7O3Forma y color:SolidPeso molecular:379.37Cadein1
Cadein1, an isoquinolinium derivative, induces G2/M phase delay and caspase-dependent apoptosis in cancer cells lacking functional p53.Fórmula:C33H48F2INO2Forma y color:SolidPeso molecular:655.64EDP-305
CAS:<p>EDP-305, an oral FXR agonist, has EC50s of 34 nM/8 nM in CHO/HEK cells, aids in PBC and NASH research with antifibrotic properties.</p>Fórmula:C36H58N2O5SForma y color:SolidPeso molecular:630.92Miclxin
CAS:Miclxin (DS37262926) is a novel MIC60 inhibitor that induces apoptosis through mitochondrial stress in mutant tumor cells via β-catenin.Miclxin is a potentFórmula:C26H27N5O2Pureza:99.17% - 99.99%Forma y color:SolidPeso molecular:441.52BiCAPPA
CAS:BiCAPPA, a bivalent antiprion, reduces scrapie-infected prion proteins with 0.32 μM efficiency.Fórmula:C38H40Cl2N6O2Forma y color:SolidPeso molecular:683.67Con B-1
CAS:ConB-1 is a potent and selective ALK inhibitor with low toxicity to normal cells .Fórmula:C38H52ClN7O6SForma y color:SolidPeso molecular:770.38JMX0293
<p>JMX0293, a salicylamide derivative, inhibits STAT3, inducing MDA-MB-231 cell apoptosis with IC50=3.38μM, while sparing MCF-10A (IC50>60μM).</p>Fórmula:C25H30Cl2N4O7Forma y color:SolidPeso molecular:569.43BM212
CAS:<p>BM212 is an antimycobacterial compound.It inhibits the growth of laboratory and clinical isolate M. tuberculosis strains.</p>Fórmula:C23H25Cl2N3Pureza:99.13%Forma y color:SolidPeso molecular:414.37SP-471P
CAS:SP-471P inhibits DENV protease; EC50: DENV1-5.9 μM, DENV2-1.4 μM, DENV3-5.1 μM, DENV4-1.7 μM; CC50 >100 μM; lowers viral RNA synthesis.Fórmula:C33H26BrN5O2Forma y color:SolidPeso molecular:604.5CPT-Se3
CAS:CPT-Se3, a camptothecin derivative, boosts anticancer activity, triggers apoptosis in Hep G2, and is cytotoxic to various cells with IC50 of 2.19-4.7 μM.Fórmula:C24H20N2O6Se2Pureza:98%Forma y color:SolidPeso molecular:590.35CPT-Se4
CAS:CPT-Se4, a seleno-derivative of CPT, effectively kills cancer cells, triggers apoptosis, and is cytotoxic against various cell lines.Fórmula:C25H24N2O7Se2Pureza:98%Forma y color:SolidPeso molecular:622.39GA-O-02
<p>GA-O-02, an 18β-Glycyrrhetinic acid derivative, inhibits NO/cytokines and fights Gram-positive bacteria; potent anti-inflammatory/antimicrobial.</p>Fórmula:C37H46ClNO6Forma y color:SolidPeso molecular:636.22GA-O-06
GA-O-06: 18β-Glycyrrhetinic acid derivative with powerful antimicrobial effects on Gram-positive bacteria and anti-inflammatory properties.Fórmula:C37H46FNO6Forma y color:SolidPeso molecular:619.76CFT8634
CAS:CFT8634 degrades BRD9, for synovial sarcoma and SMARCB1 tumor research, from patent WO2021178920A1.Fórmula:C37H45F3N6O5Forma y color:SolidPeso molecular:710.79VT02956
CAS:<p>VT02956 inhibits LATS1 (IC50: 0.76 nM) & LATS2 (0.52 nM), targets Hippo pathway, and hampers ER+ breast cancer growth.</p>Fórmula:C22H23N5OForma y color:SolidPeso molecular:373.45PF-04979064
CAS:<p>PF-04979064 is a potent and selective PI3K and mTOR dual kinase inhibitor(Ki of 0.13 nM and 1.42 nM,respectively).</p>Fórmula:C24H26N6O3Pureza:98.20% - ≥98%Forma y color:SolidPeso molecular:446.5KFU-127
KFU-127: broad-spectrum antimicrobial; targets bacterial/fungal biofilms; toxic to eukaryotic cells.Fórmula:C34H43BrN2O3Forma y color:SolidPeso molecular:607.62BAY-390
CAS:BAY-390, a selective TRPA1 inhibitor, crosses species, penetrates brains, with IC50s: 16-82 nM. Used in inflammation research.Fórmula:C13H15F4NOForma y color:SolidPeso molecular:277.26MS47134
<p>MS47134: potent MRGPRX4 agonist, EC50 = 149 nM, for pain/itch/hypersensitivity research.</p>Fórmula:C22H29NO3Forma y color:SolidPeso molecular:355.47BI-2081
CAS:<p>BI-2081: GPR40 agonist, EC50=4nM, boosts insulin, lowers blood glucose, potential for type 2 diabetes research.</p>Fórmula:C32H35FO6Forma y color:SolidPeso molecular:534.62BI-2540
CAS:<p>BI-2540 is a HIV non-nucleoside reverse transcriptase ( NNRT ) inhibitor .</p>Fórmula:C24H15ClF5NO5Forma y color:SolidPeso molecular:527.83AK-IN-1
CAS:AK-IN-1: competitive adenosine inhibitor, not ATP; inhibits AK 86-89% at 2-10 µM; promising for ischaemia, inflammation, seizure research.Fórmula:C22H21N3O4Forma y color:SolidPeso molecular:391.42DP00477
CAS:DP00477, a potent inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), exhibits an inhibitory concentration (IC50) of 7.0 µM.Fórmula:C17H11ClF3N3OSForma y color:SolidPeso molecular:397.8MK-3402
CAS:<p>MK-3402 is a metallo-beta-lactamase inhibitor. MK-3402can be used in the research of bacteria .</p>Fórmula:C15H19N9O5S2Forma y color:SolidPeso molecular:469.50MPH-220
CAS:MPH-220: Oral myosin-2 inhibitor, induces muscle relaxation, useful for spasticity research.Fórmula:C20H21N3O3SForma y color:SolidPeso molecular:383.46SDMA
CAS:<p>SDMA (Symmetric dimethylarginine) is the most potent endogenous inhibitor of nitric oxide synthase (NOS), with higher levels in patients with end-stage renal</p>Fórmula:C8H18N4O2Pureza:95.74% - ≥98%Forma y color:SolidPeso molecular:202.25ccc_R08
CAS:<p>ccc_R08 is an HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg. ccc_R08 may be investigated in HBV infections.</p>Fórmula:C22H19ClO6Pureza:99.45% - 99.86%Forma y color:SoildPeso molecular:414.84TBI-166
CAS:TBI-166, an oral riminophenazine, treats tuberculosis with fewer side effects than Clofazimine.Fórmula:C32H30F3N5O3Forma y color:SolidPeso molecular:589.61KM04416
CAS:<p>KM04416 is a GPD2 inhibitor that inhibits LUAD progression by modulating immune cell infiltration.</p>Fórmula:C12H11NO3SPureza:99.88%Forma y color:SolidPeso molecular:249.29STL1267
CAS:STL1267 is a REV-ERB agonist that crosses the blood-brain barrier and inhibits BMAL1 gene expression.Fórmula:C17H11ClN4OPureza:99.19%Forma y color:SolidPeso molecular:322.75BRD7586
CAS:BRD7586 is a cell-permeable small molecule inhibitor of SpCas9 that enhances SpCas9 specificity.Fórmula:C17H14ClN3O3S2Pureza:97.70% - 99.03%Forma y color:SolidPeso molecular:407.89TIM-063
CAS:TIM-063: ATP-competitive CaMKKα/β inhibitor, cell-permeable, Ki: 0.35/0.2 μM, IC50: 0.63/0.96 μM.Fórmula:C18H9N3O4Forma y color:SolidPeso molecular:331.28BI-3231
CAS:<p>BI-3231 is a hydroxysteroid 17ß-dehydrogenase 13 HSD17B13 inhibitor that inhibits hHSD17B13 .BI-3231 can be used to study cirrhosis.</p>Fórmula:C16H14F2N4O3SPureza:98.2%Forma y color:SolidPeso molecular:380.37NP10679
CAS:NP10679 is a N-methyl-D-aspartate (NMDA) receptor inhibitor of the GluN2B subunit that inhibits histamine H1, hERG channels, and CYPase.Fórmula:C23H26F3N3O3Pureza:99.43%Forma y color:SolidPeso molecular:449.47CZS-241
CZS-241: Oral PLK4 inhibitor (IC50=2.6 nM), less potent TRKA blocker (IC50=2.74 μM), triggers apoptosis and S/G2 arrest, anti-leukemia, safe for normal cells.Fórmula:C26H24ClF2N9OForma y color:SolidPeso molecular:551.987-Hydroxy-4H-chromen-4-one
CAS:7-Hydroxy-4H-chromen-4-one (7-hydroxy-4-benzopyrone) is a Src kinase inhibitor (IC50 of <300 μM).Fórmula:C9H6O3Pureza:97.65%Forma y color:SolidPeso molecular:162.14TH-Z145
CAS:<p>TH-Z145 is a potent FPPS inhibitor for the study of myeloma and lung cancer.</p>Fórmula:C16H28O7P2Pureza:98.29%Forma y color:SolidPeso molecular:394.34BAY-364
CAS:BAY-364 (BAY-299N) functions as an inhibitor targeting the second bromine domain in TAF1, demonstrating inhibitory effects on TAF1 in Kasumi-1 cells, CD34+Fórmula:C23H19N3O4Forma y color:SolidPeso molecular:401.41MRS4596
MRS4596: selective P2X4 blocker, IC50 1.38 μM, neuroprotective in stroke research.Fórmula:C21H14N5NaO3SForma y color:SolidPeso molecular:439.42MRS4719
CAS:<p>MRS4719: potent P2X4 antagonist, IC50 0.503 μM. Reduces infarct, brain atrophy, Ca2+ influx. Used in ischemic stroke research.</p>Fórmula:C26H13N5O3S·C6H15NForma y color:SolidPeso molecular:504.6SAHA-OH
CAS:<p>SAHA-OH selectively inhibits HDAC6 (IC50 = 23 nM) with 10-47x preference over HDACs 1, 2, 3, 8, and reduces inflammation and macrophage apoptosis.</p>Fórmula:C15H22N2O4Pureza:98%Forma y color:SolidPeso molecular:294.35Ph-HTBA
CAS:Ph-HTBA: high-affinity CaMKIIα modulator, brain-penetrant, Kd 757 nM, used in ischemia/neurodegeneration research.Fórmula:C19H18O3Forma y color:SolidPeso molecular:294.34DRP1i27
CAS:DRP1i27 inhibits human Drp1 at GTPase site, prevents mitochondrial fission, and shields cells from ischemia-reperfusion damage.Fórmula:C20H26N6OForma y color:SolidPeso molecular:366.46DN-1289
<p>DN-1289: oral, BBB-penetrating, selectively inhibits DLK (IC50=17nM) & LZK (IC50=40nM), blocks p-c-Jun in mouse optic nerve crush.</p>Fórmula:C18H19F4N7O2Pureza:98.56%Forma y color:SolidPeso molecular:441.38LWG-301
LWG-301, a GLS1 allosteric inhibitor, IC50 7 nM, impedes glutamine metabolism and prompts apoptosis; shows antitumor effects.Fórmula:C28H38N8O3SForma y color:SolidPeso molecular:566.72DS-9300
CAS:DS-9300, an orally administered potent and selective inhibitor of EP300/CBP HAT, exhibits a significant inhibitory activity with an IC50 value of 28 nM.Fórmula:C25H26F3N5O3Forma y color:SolidPeso molecular:501.50Lodenafil
CAS:Lodenafil (Hydroxyhomosildenafil) is a potent PDE5 inhibitor, with treatment of erectile dysfunction (ED)Fórmula:C23H32N6O5SPureza:99.92%Forma y color:SolidPeso molecular:504.6DDO3711
CAS:"DDO3711, a PHORC, links an ASK1 inhibitor to a PP5 activator, inhibiting ASK1 (IC50=164.1 nM), dephosphorylating p-ASK1, and showing anti-cancer potential."Fórmula:C42H41N9O6Forma y color:SolidPeso molecular:767.83BAY-805
CAS:BAY-805, a selective USP21 inhibitor, targets DUBs with high specificity.Fórmula:C24H28F3N5O2SPureza:99.49%Forma y color:SolidPeso molecular:507.57MK-8189
CAS:MK-8189 is a potent and selective pyrimidine PDE10A inhibitor, with excellent PDE (phosphodiesterase) selectivity for the treatment of schizophrenia.Fórmula:C19H22N6OSPureza:99.38% - 99.67%Forma y color:SolidPeso molecular:382.48(1R,2R)-MK-8189
CAS:(1R,2R)-MK-8189 is an isomer of MK-8189, a potent and selective pyrimidine PDE10A inhibitor.Fórmula:C19H22N6OSPureza:>99.99% - >99.99%Forma y color:SoildPeso molecular:382.48NX-2127
CAS:NX-2127 (ETX2514 Triethylamine) is an orally active BTK inhibitor that induces degradation of mutant BTKC481S in cells.NX-2127 has potent antiproliferativeFórmula:C39H45N9O5Pureza:99.07%Forma y color:SolidPeso molecular:719.83TYA-018
CAS:<p>TYA-018 is an HDAC6 inhibitor with cardioprotective effects and is used in the study of dilated heart disease and heart failure.</p>Fórmula:C15H13ClF2N4O3S2Pureza:98.64%Forma y color:SolidPeso molecular:434.87Goitrin
CAS:<p>Goitrin, from glucosinolate reactions, blocks thyroid peroxidase and iodine use, and fights H1N1.</p>Fórmula:C5H7NOSForma y color:SolidPeso molecular:129.18Pulixin
CAS:Pulixin blocks FREP1 from P. falciparum, hinders parasite spread (EC50: 11µM), and stops its growth (EC50: 47nM).Fórmula:C14H11NO4Forma y color:SolidPeso molecular:257.24SG2057
CAS:<p>SG2057 (DRG16), a PBD dimer with pentyldioxy linkage, binds DNA minor groove, forms cross-links, and is a potent antitumor agent.</p>Fórmula:C33H36N4O6Forma y color:SolidPeso molecular:584.66CU-CPT-8m
CAS:<p>CU-CPT-8m (TLR8-specific antagonist) is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM)</p>Fórmula:C14H12N4OPureza:99.00%Forma y color:SolidPeso molecular:252.27PF-184
<p>PF-184: potent IKK-2 inhibitor, selective over 30+ kinases; useful for asthma & COPD research. IC50: 37 nM.</p>Fórmula:C32H32ClFN6O4Forma y color:SolidPeso molecular:619.09YLT-11
<p>YLT-11: Oral PLK4 inhibitor, Kd 5.2 nM; less effective on PLK1/2/3; inhibits cancer cell growth and induces G2/M arrest and apoptosis.</p>Fórmula:C24H24N6OForma y color:SolidPeso molecular:412.49Erasin
Erasin is a STAT3 inhibitor induces apoptosis in various cancer cell lines (e.g., MDA-MB-231, HCC-827) and against Erlotinib-resistant cancer cells.Fórmula:C20H19N3O3Forma y color:SolidPeso molecular:349.38TPN729
CAS:TPN729, a PDE5 inhibitor, has an IC50 of 2.28 nM, used to research erectile dysfunction.Fórmula:C25H36N6O4SForma y color:SolidPeso molecular:516.66SMN-C2
CAS:<p>SMN-C2, a SMN2 gene splicing regulator, is an RNA-binding ligand that regulates pre-mRNA splicing and has potential for studying spinal muscular atrophy.</p>Fórmula:C24H27N5O2Pureza:99.14%Forma y color:SolidPeso molecular:417.5YC-001
CAS:YC-001: inverse agonist/antagonist for rod opsin, prevents light-induced retinal degeneration.Fórmula:C12H7ClO2S2Forma y color:SolidPeso molecular:282.77SHP844
CAS:SHP844: SHP2 inhibitor, IC50 18.9 µM, affects cell growth/survival by regulating tyrosine phosphorylation.Fórmula:C29H24ClN5O6Forma y color:SolidPeso molecular:573.98ME-143
CAS:ME-143, a 2nd-gen NADH oxidase inhibitor, blocks WNT/β-catenin pathway, active against various cancers in vitro/vivo.Fórmula:C21H18O4Forma y color:SolidPeso molecular:334.37JA2131
CAS:JA2131: Small PARG inhibitor, IC50 0.4μM, induces DNA damage, stalls replication, kills cancer cells.Fórmula:C13H19N5O2S2Forma y color:SolidPeso molecular:341.45Imisopasem manganese
CAS:Imisopasem manganese (M40403) is a manganese superoxide MnSOD non-peptidyl mimetic.Fórmula:C21H35Cl2MnN5Pureza:98%Forma y color:SolidPeso molecular:483.38RMG8-8
RMG8-8 shows the excellent efficacy against C. neoformans (1.56 μg/mL).Fórmula:C41H78N8O5Forma y color:SolidPeso molecular:763.11ABD957
CAS:ABD957: covalent ABHD17 depalmitoylases inhibitor, IC50 0.21µM for ABHD17B, blocks N-Ras, halts NRAS-mutant AML cell growth.Fórmula:C27H36F3N7O5SForma y color:SolidPeso molecular:627.68
